Companies
/Healthcare
Sotera Health Company
$18.06
▲ $0.23 (+1.29%) today
Markets closed · 11:13pm ET
24/7 Wall St. View
SHC at a Glance
Valuation
- Market cap
- $5.1B
- P/E ratio
- 31.3
Profitability
- Revenue (TTM)
- $1.2B
- Profit margin
- 13.4%
- EPS (TTM)
- $0.57
Price
- 52-week range
- $13 – $20
- 24/7 target
- $23.59
- Street target
- $22.72
Earnings
- Next report
- Nov 3, 2026
Headquartered in Broadview Heights, OH Fiscal year ends December NASDAQ: SHC soterahealth.com
About Sotera Health
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry. The company operates through three business segments: Sterigenics, which provides contract sterilization and ionization services using ethylene oxide (EO), gamma, and electron beam technologies; Nordion, which supplies Cobalt-60 (Co-60) and gamma technologies used in sterilization and other applications; and Nelson Labs, which provides lab testing and advisory services including microbiological and analytical chemistry testing for medical device and pharmaceutical companies. The company serves customers in highly regulated healthcare markets globally, with operations across multiple countries. Sotera Health carries approximately $2.2 billion in total debt and faces ongoing litigation related to ethylene oxide emissions from its sterilization facilities. Updated
Frequently Asked Questions
What does Sotera Health do?
Sotera Health Company is a global provider of mission-critical end-to-end sterilization solutions, lab testing, and advisory services for the healthcare industry.
What is the SHC stock price target?
24/7 Wall St.'s 12-month price target for SHC is $23.59, rated Buy. The Wall Street consensus target is $22.72. SHC price prediction →